Machine learning, also known as artificial intelligence, could be a useful tool for predicting how well people at high risk of psychosis or with recent onset depression will function socially in the future, an international research study has found.
The research team, led in Australia by Professor Stephen Wood from Orygen, the National Centre of Excellence in Youth Mental Health, evaluated whether clinical, neuroimaging-based, or machine-learning methods could better predict patients’ social outcomes (e.g., their ability to undertake social interactions, or create and maintain relationships with others) than methods currently in use. In all three approaches the results of brain imaging and clinical measures from client interviews were analysed.
Professor Wood said the research team found that machine learning outperformed human experts and could correctly predict social outcomes one year later in up to 83 per cent of patients in clinical high-risk states for psychosis and 70 per cent of patients with recent-onset depression.
“Predicting social outcomes is important as among young people and emerging adults in OECD countries the top causes of ‘disability’ – and poor social functioning is included in that – are mostly disorders of mental health, including those that typically present with a first episode of psychosis,” Professor Wood said.
“By being able to better predict what will happen to people at high risk of psychosis or with recent onset depression over time, we are able to provide individualised treatments to clients when they first present to mental health services and potentially improve their social functioning.
For the study the research team followed 116 people at clinical high-risk of developing psychosis and 120 people experiencing recent onset depression aged 15 to 40, as well as 176 healthy control participants.
Learn more: AI could be used to predict outcomes for people at risk of psychosis and depression
The Latest on: Artificial intelligence diagnostics
[google_news title=”” keyword=”artificial intelligence diagnostics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Artificial intelligence diagnostics
- Reducing clerical duties and paperwork will free healthcare staff to spend more time on clinical careon May 7, 2024 at 9:00 pm
Generative AI is set to have a truly transformative impact on the health service, from patient outcomes and clinical research to the basic administration ...
- Dr. AI will see you nowon May 7, 2024 at 8:10 pm
Artificial intelligence in health care is expanding fast in everything from robotics to disease surveillance and letters from your provider.
- Quest Diagnostics (DGX) Grows in Digital Pathology With New Dealon May 7, 2024 at 8:23 am
Quest Diagnostics DGX recently announced a strategic collaboration with PathAI, a global leader in artificial intelligence-powered pathology technology, aimed at revolutionizing cancer and disease ...
- Quest plans to purchase PathAI’s diagnostic lab as part of AI ramp-upon May 6, 2024 at 9:18 am
AI and digital technologies have tremendous potential to improve cancer care, and Quest has the know-how to scale and deliver innovations that are high quality, efficient and broadly accessible," said ...
- Artificial Intelligence in Diagnostics Market CAGR of 32.3%, Size Poised for Takeoff in the Coming Yearson May 5, 2024 at 2:43 pm
Artificial Intelligence in Diagnostics Market is valued approximately at USD 288 million in 2019 and is anticipated to grow with a healthy growth rate of more than 32.3% over the forecast period ...
- What is Artificial General Intelligence (AGI), and why are people worried about it?on May 5, 2024 at 5:33 am
AGI refers to a machine or a software that can perform any intellectual task that a human can do. This includes reasoning, common sense, abstract thinking, background knowledge, transfer learning, ...
- Quest Finds its Path to AI in Cancer Diagnostics Through M&Aon May 1, 2024 at 10:25 am
Quest Diagnostics has found its path to artificial intelligence in cancer diagnosis through M&A. The Secaucus NJ-based company said it was acquiring select assets of PathAI Diagnostics, the business ...
- Quest Diagnostics carves out PathAI's digital pathology lab, plots AI ramp-upon May 1, 2024 at 7:30 am
Quest Diagnostics is building out its artificial intelligence-powered cancer pathology offerings through a multi-layered deal with PathAI—acquiring some assets, licensing out others. | Quest ...
- Quest Diagnostics To Acquire Select Assets Of PathAI Diagnostics - Quick Factson May 1, 2024 at 4:31 am
Quest Diagnostics (DGX) and PathAI, a global provider of artificial intelligence-powered technology for pathology, announced ...
via Bing News